BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li M, Wang H, Li W, Peng Y, Xu F, Shang J, Dong S, Bu L, Wang H, Wei W, Hu Q, Liu L, Zhao Q. Identification and validation of an immune prognostic signature in colorectal cancer. Int Immunopharmacol 2020;88:106868. [PMID: 32771948 DOI: 10.1016/j.intimp.2020.106868] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Yu F, Liu Z, Wang X, Li J. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer. Cancer Biother Radiopharm 2022;37:963-75. [PMID: 34551265 DOI: 10.1089/cbr.2021.0171] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Cai Z, Zhou F. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer. Medicine (Baltimore) 2022;101:e31127. [PMID: 36401385 DOI: 10.1097/MD.0000000000031127] [Reference Citation Analysis]
3 Li X, Huo X, Zhao C, Chen Z, Xu Z, Yu J, Sun X. A novel chromatin regulator signature predicts the prognosis, clinical features and immunotherapy of colon cancer. Epigenomics 2022;14:1325-41. [PMID: 36545887 DOI: 10.2217/epi-2022-0266] [Reference Citation Analysis]
4 Lin Y, Xiao Y, Liu S, Hong L, Shao L, Wu J. Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer. BMC Med Genomics 2022;15:221. [PMID: 36280825 DOI: 10.1186/s12920-022-01369-8] [Reference Citation Analysis]
5 Huang Y, Zhou J, Zhong H, Xie N, Zhang F, Zhang Z. Identification of a novel lipid metabolism-related gene signature for predicting colorectal cancer survival. Front Genet 2022;13:989327. [DOI: 10.3389/fgene.2022.989327] [Reference Citation Analysis]
6 Liu Y, Chen L, Meng X, Ye S, Ma L. Identification of Hub Genes in Colorectal Adenocarcinoma by Integrated Bioinformatics. Front Cell Dev Biol 2022;10:897568. [DOI: 10.3389/fcell.2022.897568] [Reference Citation Analysis]
7 Xiong K, Tao Z, Zhang Z, Wang J, Zhang P. Identification and Validation of a Prognostic Immune-Related Gene Signature in Esophageal Squamous Cell Carcinoma. Front Bioeng Biotechnol 2022;10:850669. [DOI: 10.3389/fbioe.2022.850669] [Reference Citation Analysis]
8 Guo T, Wang Z, Liu Y. Establishment and verification of a prognostic tumor microenvironment-based and immune-related gene signature in colon cancer. J Gastrointest Oncol 2021;12:2172-91. [PMID: 34790383 DOI: 10.21037/jgo-21-522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Subtil B, Cambi A, Tauriello DVF, de Vries IJM. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer. Front Immunol 2021;12:724883. [PMID: 34691029 DOI: 10.3389/fimmu.2021.724883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Li Y, Ma Y, Wu Z, Zeng F, Song B, Zhang Y, Li J, Lui S, Wu M. Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis. Front Immunol 2021;12:751407. [PMID: 34659255 DOI: 10.3389/fimmu.2021.751407] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
11 Li X, Xie M, Yin S, Xiong Z, Mao C, Zhang F, Chen H, Jin L, Lan P, Lian L. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer. Front Genet 2021;12:666003. [PMID: 34017356 DOI: 10.3389/fgene.2021.666003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]